BioSig Technologies today announced it appointed Anthony Amato as CEO, effective immediately. Amato will serve on the company’s board of directors, which is currently being assembled. He joins the company from consulting firm Bridge Associates International Pharmaceutical Consulting (BAIPC). Westport, Connecticut-based BioSig Technologies announced earlier this month that the company engaged with BAIPC as a […]
BioSig Technologies
BioSig reduces workforce again, will ‘substantially’ cut operations
BioSig Technologies (Nasdaq:BSGM) announced today that it terminated “a significant number of its employees.” Shares of BSGM were up 3.1% to 64¢ apiece in mid-morning trading today following the announcement. With this latest workforce reduction, the company says it expects to “substantially reduce business operations.” Today’s announcement marks the company’s second significant headcount cut in […]
BioSig announces layoffs as part of cost-cutting effort
BioSig Technologies (Nasdaq:BSGM) announced today that it enacted a workforce reduction in an effort to reduce cash burn. Westport, Connecticut-based BioSig did not disclose the number of employees affected by the reduction. As of the company’s last annual report on March 30, 2023, it had 47 full-time employees. Shares of BSGM fell 4.3% to 21¢ […]
BioSig expands R&D for machine learning, AI for cardiac arrhythmia treatment
BioSig Technologies (Nasdaq:BSGM) announced that it entered a collaboration with Reified Labs to advance its R&D efforts. The collaboration with Reified Labs, a technical advisory partner, advances the R&D of an AI-based medical device platform. BioSig plans to base the foundational machine learning model for the device on integrated healthcare datasets. That starts with ECG […]
BioSig Technologies regains Nasdaq compliance
BioSig Technologies (Nasdaq:BSGM) announced today that it received notice from the Nasdaq market that it regained compliance. Westport, Connecticut-based BioSig regained compliance with the minimum bid price requirement. Shares of BSGM closed at or above $1 apeice for a period of 10 consecutive days earlier this month. The compliance period took place between Feb. 6 […]
BioSig expects to raise $3.5M from public offering
BioSig Technologies (Nasdaq:BSGM) announced today that it priced a previously announced public offering at $3.5 million. Westport, Connecticut–based BioSig’s best efforts, underwritten public offering totals up to 4,666,667 shares of its common stock, $0.001 par value per share, at a price to the public of $0.75 per share, bringing the gross proceeds to $3.5 million. […]
BioSig Technologies partners with Summit Blue Capital to provide leasing and financing for Pure EP signal processing system
BioSig Technologies today announced that it is partnering with Summit Blue Capital to implement a leasing and finance program for the company’s Pure EP system. Minneapolis-based Summit Blue Capital offers tailored leasing and financing for partners and clients in healthcare, manufacturing, hospitality, technology and more. Through the partnership, BioSig will be able to offer a […]
BioSig Technologies announces $3M offering
BioSig Technologies (Nasdaq:BSGM) announced today that it entered into a definitive purchase agreement to sell $3 million in common stock. Westport, Connecticut-based BioSig agreed to sell $3 million in common stock and warrants in the agreement led by a family office with expertise in small-cap emerging growth investing. Under the agreement, BioSig will issue 2,611,739 […]
BioSig Technologies appoints former Abbott executive as chief operating officer
BioSig Technologies (NSDQ:BSGM) today announced that it has appointed John Sieckhaus as chief operating officer. Sieckhaus joins BioSig — a creator of a proprietary biomedical signal processing platform — with 30 years of experience in the healthcare industry. He has served in numerous leadership roles at St. Jude Medical and Abbott Labs, including SVP and GM. […]
BioSig Technologies appoints chief commercial officer
BioSig Technologies today announced that it has appointed Gray Fleming as chief commercial officer. Most recently, Fleming served as chief commercial officer at Carecube, which is developing a temporary and scalable negative pressure isolation technology. “I am extremely excited to be returning to the electrophysiology arena and, most importantly, dedicating effort and energy towards supporting […]
BioSig, Mayo Clinic announce AI development partnership
BioSig Technologies (NSDQ:BSGM) will work with the Mayo Foundation for Medical Education and Research to develop next-gen, AI-powered software for its Pure EP system, which is meant to take electrophysiology to the next level. The Mayo Clinic has already been an important investor and development partner for the Westport, Conn.–based company. BioSig signed a 10-year collaboration […]
